SLG
Stanley-Laman Group Portfolio holdings
AUM
$673M
1-Year Return
14.64%
This Quarter Return
+4.57%
1 Year Return
+14.64%
3 Year Return
+60.49%
5 Year Return
+79.33%
10 Year Return
+186.95%
AUM
$850M
AUM Growth
+$81.1M
(+11%)
Cap. Flow
+$35.9M
Cap. Flow
% of AUM
4.22%
Top 10 Holdings %
Top 10 Hldgs %
17.3%
Holding
316
New
63
Increased
100
Reduced
42
Closed
58
Top Buys
| 1 |
Robinhood
HOOD
|
$10.6M |
| 2 |
SiTime
SITM
|
$10.5M |
| 3 |
Snap
SNAP
|
$10.4M |
| 4 |
Ambarella
AMBA
|
$10.3M |
| 5 |
Enphase Energy
ENPH
|
$10M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$21.1M |
| 2 |
Repligen
RGEN
|
$11.9M |
| 3 |
Salesforce
CRM
|
$11.7M |
| 4 |
MSCI
MSCI
|
$11.1M |
| 5 |
Morningstar
MORN
|
$11M |
Sector Composition
| 1 | Technology | 40.55% |
| 2 | Healthcare | 13.49% |
| 3 | Communication Services | 6.46% |
| 4 | Financials | 6.22% |
| 5 | Industrials | 5.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Bally's
BALY
$454M
| $1.78M | 0.21% |
46,670
+7,500
| +19% | +$285K |
|
127
Castle Biosciences
CSTL
$683M
| $1.71M | 0.2% |
+39,974
| New | +$1.71M |
|
128
Adaptive Biotechnologies
ADPT
$1.96B
| $1.71M | 0.2% |
61,061
+44,364
| +266% | +$1.24M |
|
129
eXp World Holdings
EXPI
$1.76B
| $1.67M | 0.2% |
+49,700
| New | +$1.67M |
|
|
XYZ
130
Block, Inc.
XYZ
$45.7B
| $1.67M | 0.2% |
+10,310
| New | +$1.67M |
|
131
Workiva
WK
$4.48B
| $1.64M | 0.19% |
+12,551
| New | +$1.64M |
|
|
SUMO
132
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
| $1.6M | 0.19% |
+118,298
| New | +$1.6M |
|
133
Natera
NTRA
$23.1B
| $1.54M | 0.18% |
+16,447
| New | +$1.54M |
|
134
Southwest Airlines
LUV
$16.5B
| $1.53M | 0.18% |
35,724
+8,925
| +33% | +$382K |
|
|
PLAN
135
DELISTED
Anaplan, Inc.
PLAN
| $1.52M | 0.18% |
33,097
+23,130
| +232% | +$1.06M |
|
136
Quanterix
QTRX
$211M
| $1.36M | 0.16% |
32,090
+21,373
| +199% | +$906K |
|
137
Upwork
UPWK
$2.15B
| $1.34M | 0.16% |
39,152
+26,404
| +207% | +$902K |
|
138
Realty Income
O
$54.2B
| $1.31M | 0.15% |
+18,285
| New | +$1.31M |
|
|
EGRX
139
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.22M | 0.14% |
24,000
| – | – |
|
140
Advanced Micro Devices
AMD
$245B
| $1.13M | 0.13% |
7,863
+317
| +4% | +$45.6K |
|
141
Teradyne
TER
$19.1B
| $1.07M | 0.13% |
6,562
+701
| +12% | +$115K |
|
142
Synopsys
SNPS
$111B
| $1M | 0.12% |
2,723
-28,220
| -91% | -$10.4M |
|
|
143
Morningstar
MORN
$10.8B
| $967K | 0.11% |
2,827
-32,086
| -92% | -$11M |
|
|
144
MSCI
MSCI
$42.9B
| $945K | 0.11% |
1,543
-18,074
| -92% | -$11.1M |
|
145
JPMorgan Chase
JPM
$809B
| $937K | 0.11% |
5,917
+1
| +0% | +$158 |
|
146
West Pharmaceutical
WST
$18B
| $907K | 0.11% |
1,933
| – | – |
|
147
Bank of America
BAC
$369B
| $851K | 0.1% |
19,120
| – | – |
|
148
Thermo Fisher Scientific
TMO
$186B
| $757K | 0.09% |
1,135
-458
| -29% | -$305K |
|
149
CVS Health
CVS
$93.6B
| $705K | 0.08% |
6,833
| – | – |
|
|
GTM
150
ZoomInfo Technologies
GTM
$3.26B
| $492K | 0.06% |
+7,661
| New | +$492K |
|